Ipamorelin: Growth Hormone Peptide Benefits, Dosage, and What to Expect
Medically reviewed by Medical Advisory Board Last reviewed 2026-05-13
The cleanest growth hormone secretagogue — how ipamorelin works, what it does, and how it stacks with CJC-1295
Ipamorelin is a pentapeptide (5 amino acids) that selectively stimulates growth hormone release from the anterior pituitary. It was developed in the 1990s and studied initially by Novo Nordisk. Unlike older GHRPs (growth hormone-releasing peptides) like GHRP-2 and GHRP-6, ipamorelin is highly selective — it significantly raises GH without meaningfully increasing cortisol, prolactin, or appetite, making it the preferred GHRP for most clinical protocols.
Ipamorelin is almost always stacked with a GHRH analog (typically CJC-1295 or modified GRF 1-29) to create a dual-action GH pulse: the GHRH increases the amplitude of the pulse, while the GHRP (ipamorelin) increases the frequency and selectivity. This combination produces a more physiologically normal GH release pattern than either compound alone. Ipamorelin is a popular starting point for growth-hormone peptide therapy.
Want expert help with your hormone health?
We can match you with a board-certified hormone specialist who understands this area — so you get the right doctor, not just any doctor.
Book An Appointment With A Specialist →Ipamorelin Benefits
- Growth hormone stimulation: Ipamorelin produces dose-dependent GH release from the pituitary, raising IGF-1 levels. Unlike exogenous HGH, this preserves the pulsatile pattern and pituitary-hypothalamic feedback loop.
- Body composition: Elevated GH and IGF-1 support lean mass preservation, fat metabolism (particularly visceral fat), and improved body composition over 3–6 month protocols.
- Recovery and sleep: GH is predominantly released during deep sleep. Ipamorelin administered at bedtime amplifies this natural pulse, improving tissue repair and sleep quality.
- Bone density: IGF-1 stimulates osteoblast activity; long-term GH optimization supports bone density preservation.
- Anti-aging: GH declines approximately 15% per decade after age 30 (somatopause). GH secretagogues address this decline without the risks of exogenous HGH.
Ipamorelin Dosage (Research Reference)
Standard ipamorelin protocols from clinical research and compounding pharmacy guidance:
- Dose range: 200–300 mcg per injection, 1–3 times daily
- Most common protocol: 200–300 mcg once daily at bedtime (to amplify the natural nocturnal GH pulse)
- Advanced protocols: 200 mcg 2–3x daily (morning before exercise, around workout, and bedtime) to maximize GH pulsatility throughout the day
- Stacked with CJC-1295: Ipamorelin 200–300 mcg + CJC-1295 (no DAC) 100–200 mcg per injection, 1–3x daily
- Cycle length: 3–6 months on, with 1–2 months off to prevent pituitary desensitization
Ipamorelin vs GHRP-2 and GHRP-6
| Peptide | GH Stimulation | Cortisol Effect | Appetite Effect | Selectivity |
|---|---|---|---|---|
| Ipamorelin | Strong | Minimal | Minimal | High |
| GHRP-2 | Very strong | Moderate increase | Moderate increase | Lower |
| GHRP-6 | Strong | Moderate increase | Strong increase (hunger) | Lower |
| Hexarelin | Very strong | High increase | Moderate | Lowest |
Ipamorelin's selectivity is its key advantage. The significant cortisol and prolactin spikes from GHRP-2 and GHRP-6 can blunt the anabolic effect of GH and cause side effects that make those compounds less suitable for long-term anti-aging protocols.
Choosing between a GHRP and a GHRH analog? See our ipamorelin vs sermorelin comparison for how the two pathways differ and why they're often stacked.
What to Expect: Timeline
- Week 1–2: Improved sleep quality and depth (often the first reported benefit). Some users notice better post-workout recovery.
- Week 3–4: Energy levels often improve. Lab results begin showing IGF-1 movement from baseline.
- Month 2–3: Body composition changes become measurable — modest lean mass increase, some visceral fat reduction with appropriate diet.
- Month 4–6: More substantial body composition changes, skin quality improvements, and recovery benefits are typically most pronounced in this window.
Frequently Asked Questions
What is ipamorelin?
Ipamorelin is a synthetic pentapeptide (5 amino acid chain) that acts as a selective growth hormone secretagogue — it stimulates the pituitary gland to release growth hormone in a pulsatile, physiologically normal pattern. It's selective for GH release without significantly raising cortisol, prolactin, or appetite, which distinguishes it from older GHRPs like GHRP-6.
What does ipamorelin do?
Ipamorelin stimulates the pituitary to release growth hormone, which raises IGF-1 levels and produces downstream effects on body composition (lean mass preservation, fat metabolism), tissue repair and recovery, sleep quality, bone density, and the general aging process associated with declining GH (somatopause).
What is the ipamorelin dosage?
Standard ipamorelin dosage in clinical and research protocols is 200–300 mcg per injection, typically administered once daily at bedtime or 2–3 times daily. It's almost always stacked with a GHRH analog like CJC-1295 (100–200 mcg) to produce a synergistic GH pulse. These are research reference ranges, not medical advice.
Does CJC-1295 ipamorelin work?
The CJC-1295 + ipamorelin combination is one of the most evidence-backed growth hormone peptide stacks. CJC-1295 (a GHRH analog) increases the amplitude of GH pulses, while ipamorelin (a GHRP) increases frequency and selectivity. Together they produce a synergistic effect on GH release that exceeds either compound alone, with a cleaner side effect profile than exogenous HGH.
Topic updates
Get the weekly peptide roundup
Peptide therapy, GLP-1s, growth hormone peptides, healing peptides, safety notes, and comparison guides.
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Reading
-
CJC-1295 + Ipamorelin Stack: Dosing Protocol, Timing & Results
CJC-1295 + ipamorelin stack: why they're synergistic, full dosing protocol, and results timeline.
-
Ipamorelin + HGH Fragment 176-191 Stack: Fat Loss Protocol and Dosing
Ipamorelin + HGH frag 176-191 stack for fat loss — dosing protocol and cycle guide.
-
Ipamorelin vs Sermorelin: GH Peptide Pathways, Dosing, and Which to Choose
Ipamorelin vs sermorelin: GHRP vs GHRH analog, mechanisms, dosing, and why they're stacked.
See more related reading
-
MK-677 vs Ipamorelin: Oral vs Injectable Growth Hormone Secretagogues
MK-677 vs ipamorelin: oral ghrelin agonist vs selective injectable GHRP.
-
Tesamorelin vs Ipamorelin: GHRH Analog vs Selective GHRP Compared
Tesamorelin vs ipamorelin: GHRH analog vs selective GHRP, often combined not substituted.